| Literature DB >> 34987319 |
Haiyan Shao1, Peihong Shen2, Junfeng Chen1.
Abstract
The expression profile and image observation of miRNA in serum of patients with obstructive sleep apnea-hypopnea syndrome were investigated. Bioinformatics methods were used to explore the molecular mechanism of obstructive sleep apnea-hypopnea syndrome (OSAHS)-related hypertension and explore the differentially expressed core miRNAs and regulatory factors, providing a theoretical basis for seeking molecular targets for clinical diagnosis and treatment. The miRNA datasets of patients with OSAHS and those with hypertension were downloaded from the public database to obtain differentially expressed miRNAs and explore the biological processes and pathways involved in the target genes. The core miRNAs and competitive endogenous RNA (ceRNA) transcription factors (TFs) were obtained by database mining and Cytoscape network analysis. The results showed that 2,579 differentially expressed miRNAs were obtained from the GSE112093 dataset. Seven upregulated miRNAs (hsa-miR-7107-5p, hsa-miR-7110-5p, hsa-miR-595, hsa-miR-1268b, hsa-miR-3064-5p, hsa-miR-68565p, and hsa-miR-1180-3p) and one downregulated miRNA (hsa-miR-22-3p) were obtained from the GSE112093 dataset. It is proved that hsa-miR-22-3p, hsa-miR-595, hsa-miR-6856-5pKcnq1ot1, neat1, Tsix, ERG, kdm2b, and Runx1 may be involved in the pathogenesis of OSAHS-related hypertension, which provided a theoretical basis for the mechanism research and clinical treatment of OSAHS.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34987319 PMCID: PMC8691998 DOI: 10.1155/2021/9731502
Source DB: PubMed Journal: Contrast Media Mol Imaging ISSN: 1555-4309 Impact factor: 3.161
Figure 1Flowchart of research and design.
Figure 2Differential miRNA analysis.
miRNA related to essential hypertension.
| Biomarkers | Expression situation | Organization source | PMID |
|---|---|---|---|
| miR-133b | Lower | Blood plasma | 21924071 |
| miR-7-5p | Higher | Serum | 29069223 |
| miR-26b-5p | Higher | Serum | 29069223 |
| miR-26b | Lower | Peripheral blood mononuclear cells | 26358152 |
| miR-133a | Lower | Peripheral blood mononuclear cells | 26358152 |
| miR-155 | Higher | Vein endothelial cells | 21234519 |
| miR-21 | Higher | Blood | 24284386 |
| miR-21 | Higher | Peripheral blood mononuclear cells | 26358152 |
| miR-499 | Higher | Peripheral blood mononuclear cells | 26358152 |
| miR-143 | Higher | Peripheral blood leukocytes | 29609545 |
| miR-510 | Higher | Blood | 27881848 |
| miR-145 | Lower | Blood | 24284386 |
| miR-133 | Lower | Blood | 24284386 |
| miR-1 | Higher | Peripheral blood mononuclear cells | 26358152 |
| miR-1 | Higher | Blood | 24284386 |
| miR-296-5p | Lower | Blood plasma | 21924071 |
| miR-296-5p | Lower | Blood plasma | 21690488 |
| hem-i-112 | Higher | Blood plasma | 21690488 |
| hem-1-i-1112 | Higher | Blood plasma | 21924071 |
| l | Higher | Blood plasma | 21924071 |
| l | Higher | Blood plasma | 21690488 |
| miR-208b | Higher | Peripheral blood mononuclear cells | 26358152 |
Figure 3KEGG analysis of target gene.